Clinical Trial Inspection Findings: What Sponsors Need to Know
Clinical Trial Inspection Findings: What Sponsors Need to Know Essential Insights for Sponsors on Clinical Trial Inspection Findings Introduction: Why Sponsors Must Prioritize Inspection Readiness Clinical trial inspections are critical mechanisms used by regulatory authorities such as the FDA, EMA, MHRA, and PMDA to evaluate compliance with ICH GCP, regional laws, and ethical standards. Findings…
Read More “Clinical Trial Inspection Findings: What Sponsors Need to Know” »